Keywords
Osteoporosis
Glycemic control
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objectives: To analyze the presence of risk factors associated with the development of bone fragility in type 2 diabetic patients. Methods: A cross-sectional, observational and analytical-descriptive study was carried out, based on the application of a questionnaire and analysis of medical records of diabetic patients, from june to august of 2022, with convenience sample. Results: A sample of 80 patients was used, being 72,5% female, aged between 51-70 years (58,8%), diagnosed with diabetes for more than 10 years (52,5%) and with glycated hemoglobin levels below 8,5% (77,5%). Among those surveyed, it was identified as an additional risk for the development of bone fragility: use of antidiabetic medications that have an effect on bone metabolism and/or that increase the risk of hypoglycemia (66,3%), history of smoking (48,8 %), chronic use of corticosteroids (16,3%) and previous fragility fracture (8,8%). Only 42,5% had a bone densitometry record in their medical records and, of these, the majority (67,6%) had diagnosis of osteoporosis. In this population, a total of 46,3% had an average fracture risk calculated by FRAX®. Conclusion: Bone fragility should be considered a complication of diabetes, and the design of prevention and screening strategies of this condition is essential.
References
ALETI S, et al. Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India. Revista Eletrônica Jornal Internacional de Diabetes em Países em Desenvolvimento, 2020; 40(2):262-268.
BEEVE AT, et al. Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes. Curr Osteoporos Rep, 2019; 17(5):256-269.
COMPSTON J. Type 2 diabetes mellitus and bone. Revista Científica Journal of Internal Medicine, 2018; 283(2):140-153.
FERRARI S, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int, 2018; 29: 2585–2596.
INÁCIO AM. Incidência de fraturas e perfil clínico de pacientes acompanhados em um serviço de prevenção secundária de fraturas por fragilidades óssea na cidade de Curitiba. Dissertação (Mestrado em Medicina Interna e Ciências da Saúde) – Setor de Ciências da Saúde Universidade Federal do Paraná, Curitiba, 2021.
International Diabetes Federation Atlas. 2021. Disponível em: https://diabetesatlas.org/atlas/tenth-edition/. Acessado em: 8 de setembro de 2021.
JANG M, et al. Effect of duration of diabetes on bone mineral density: a population study on East Asian males. BMC Endocrine Disorders, 2018; 18: 61.
KDIGO Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. 2022. Disponível em: https://kdigo.org/wp-content/uploads/2022/10/KDIGO-2022-Clinical-Practice-Guideline-for-Diabetes-Management-in-CKD.pdf. Acessado em: 8 de setembro de 2021.
LIN HH, et al. Association between type 2 diabetes and osteoporosis risk: a representative cohort study in Taiwan. Revista Científica PLOS ONE, 2021; 16(7):e0254451.
NAGANO CP. Osteoporose induzida por glicocorticoides: expressão salivar de biomarcadores ósseos em pacientes submetidos à corticoterapia prolongada e sua correlação radiomorfométrica. Tese (Doutorado em Odontologia) – Área de Concentração: Diagnóstico Bucal, Radiologia Odontológica e Imaginologia Faculdade de Odontologia da Universidade de São Paulo, São Paulo, 2018.
NAPOLI N, et al. Mechanisms of diabetes mellitus-induced bone fragility Mechanisms of diabetes mellitus-induced bone fragility. Nature Reviews Endocrinology, 2017; 13(4):208- 219.
NATHAN DM, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993; 329(14):977-86.
PEDRO AO, et al. Manual brasileiro de osteoporose: orientações práticas para os profissionais de saúde 1. ed. -- São Paulo : Editora Clannad, 2021.
PITITTO B, et al. Metas no tratamento do diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes, 2022.
RIBEIRO RF, et al. Fratura por fragilidade: fatores de risco em uma coorte retrospectiva. Revista Eletrônica Acta Fisiátrica, 2022; 29(3):177-83.
ROLIM L, et al. Diagnóstico e tratamento da neuropatia periférica diabética. Diretriz Oficial da Sociedade Brasileira de Diabetes, 2022.
SAFAROVA SS. The impact of metabolic changes in type 2 diabetes on bone turnover. Revista Eletrônica Medicni Perspektivi, 2018; 23(2):143-7.
SONG P, et al. Canagliflozin promotes osteoblastic MC3T3-E1 differentiation via AMPK/RUNX2 and improves bone microarchitecture in type 2 diabetic mice. Front. Endocrinol., 2022; 13:1081039.
SOUSA CJ e OLIVEIRA MLC. FRAX tool in Brazil: an integrative literature review following validation. Revista Brasileira de Geriatria e Gerontologia, 2018; 21(1).
SOUZA BGS, et al. Profilaxia primária e secundária de fraturas osteoporóticas: avaliação de uma coorte prospectiva. Rev Bras Ortop., 2017; 52(5): 538-43.
SOUZA GOMES TP, et al. Obesidade, Diabetes Mellitus tipo 2 e fragilidade óssea: uma revisão narrativa. Revista Eletrônica HU, 2019; 44(2): 241-9.
VAINICHER CE, et al. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility. Jornal de Pesquisa em Diabetes, 2020; 7608964.
VALDERRÁBANO R.J, et al. Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol, 2018; 4: 9.
WALSH J.S e VILACA T. Obesity, Type 2 Diabetes and Bone in Adults. Calcif Tissue Int, 2017; 100: 528–535.
ZERBINI CA. FRAX Modelo Brasil: um texto clínico explicativo sobre limiares para intervenção terapêutica. Diagnóstico e Tratamento. Biblioteca Virtual em Saúde, 2019; 24(2): [41-49].